Red Flags in Stem Cell Clinics: What Transparent Providers Do Differently

The clearest red flag is being charged for a stem cell product that is not FDA-approved, outside a clinical trial. The FDA says that if you are “being charged for these products or offered these products outside of a clinical trial, you are likely being deceived” (FDA).

Many of the other warning signs are not scientific claims at all. They are sales techniques: ways of borrowing authority, creating urgency, making a price feel smaller or a risk feel absent. Each one works for an understandable reason, and knowing the reason makes it easier to notice in the moment. For each pattern below, the last line describes what a transparent provider does instead.

What does each pattern sound like?

What you hear	The pattern
"FDA-registered," "our study is on ClinicalTrials.gov," "board-certified in regenerative medicine"	Borrowed authority
Videos, testimonials, before-and-after stories	Social proof
"This price is only good today," a free seminar that ends with booking, "the window is closing"	Urgency
A price per joint, a package deal, an add-on "to boost results"	Price framing
"It's your own cells, so it's safe," "no side effects"	Risk minimization
"We treat arthritis, autism, Parkinson's and heart disease"	Cure-all breadth
"It regenerates cartilage," "research suggests," a "stem cell count" with no method	Precise-sounding vocabulary
"Your doctor doesn't know about this," advice to stop your medicines	Separating you from your doctor
"The first one didn't work, so let's try the stronger version"	Escalation after failure

How does each pattern work, and what does a transparent provider do instead?

Borrowed authority

A registration number, a trial listing or a certificate looks like an official stamp, and checking what each one actually means takes time and background that a visitor may not have on hand. The FDA says a ClinicalTrials.gov listing or FDA registration “does not mean the product is legally marketed” (FDA, above). Certificates work the same way: the American Board of Medical Specialties notes that “There are a number of non-ABMS and self-designated medical boards in the United States” and that it cannot verify their requirements (ABMS). A “study” is borrowed authority too when you pay full price to join it; the International Society for Stem Cell Research says “It is not customary to pay to be in a clinical trial (other than perhaps travel and other personal expenses)” (<a href="https://static1.squarespace.com/static/611faaa8fee682525ee16489/t/65f09b1918aebc21ebd37efe/1710267161381/ISSCRPatientHandbookv12Feb2024Redesignv4b.pdf”>ISSCR Guide to Stem Cell Treatments, 2024).

A transparent provider names the exact rule that lets it offer the product, says plainly what is not approved, and, if there is a study, gives you a trial number, the name of the ethics committee and a research consent form. Which rules apply is set out on the page on FDA status and what clinics can legally offer.

Social proof

A story about someone like you who got better is more vivid than a table of averages, and it is hard to argue with. Heavy reliance on testimonials is an ISSCR warning sign (ISSCR, above), and testimonials featured in a 2018 FTC case against a clinic that advertised amniotic “stem cell therapy” (FTC, 2018). What a story cannot show is what would have happened without the injection. In the knee trials pooled by Cochrane, about 53 in 100 people given a placebo injection reported treatment success (<a href="https://www.cochrane.org/evidence/CD013342what-are-benefits-and-risks-stem-cell-injections-knee-osteoarthritis”>Cochrane).

A transparent provider gives you numbers with a comparison group and names the trials that found no benefit, as well as the ones that did.

Urgency

A deadline changes the question from “is this right for me?” to “will I miss out?”, and it leaves no time for a second opinion or a proper read of the consent form. The FTC’s 2021 complaint against a company that trained and supplied clinics described free seminars for seniors followed by attempts to schedule attendees (FTC, 2021). The medical version of urgency is the claim that a “window” for treating your joint is closing; none of the trials cited on this site shows that injecting earlier prevents later damage.

A transparent provider gives you a written plan and price and expects you to take them home. A consent checklist shows what a complete form contains.

Price framing

Quoting per joint, per injection or per “package” makes the first number smaller than the final bill. In the same 2021 complaint, the clinic charged about $5,000 per joint injection, and many patients had more than one (FTC, 2021, above). Add-ons offered “to boost results” work similarly; none of the trials cited on this site tested a combination against the single treatment.

A transparent provider puts the whole course in writing, including repeat injections, what happens if the sample on the day is unusable, and the refund policy.

Risk minimization

“Your own cells” sounds safe, and it does remove the risk of rejection. It does not remove the risks of a needle in the hip bone or a joint. A claim of no risk is an ISSCR warning sign (ISSCR, above), and the FDA lists harms from unapproved products that include blindness, tumor formation, and bacterial infections including life-threatening blood infections (FDA, above).

A transparent provider describes the risks of the harvest and of the injection, and gives you written warning signs and an after-hours number. These are the same warning signs after an injection that need a call that apply to any joint injection.

Cure-all breadth

A treatment that seems to work for many diseases sounds powerful. In medicine that breadth is itself a warning sign, because treatments are tested and approved for specific uses. One cell type marketed for many unrelated diseases is an ISSCR warning sign (ISSCR, above). The 2018 FTC case involved amniotic “stem cell therapy” advertised for conditions from Parkinson’s disease and autism to osteoarthritis and kidney disease (FTC, 2018, above), and in 2019 the FDA announced a federal court decision that a clinic and its chief scientific officer “adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue,” which the clinic had used for conditions including Parkinson’s disease, ALS, heart disease and lung disease (FDA, 2019).

A transparent provider can tell you which patients it does not treat and where it sends them.

Precise-sounding vocabulary

Some phrases sound specific while committing to nothing. The test is whether the answer names a number, a comparison group and a source.

What you hear	The problem	What a transparent answer sounds like
"Many patients report improvement"	No count and no comparison; people in placebo groups improve too	"In placebo-controlled knee trials, pain was about 1.2 points lower on a 10-point scale at three to six months, and reviewers rated that evidence low certainty" (Cochrane)
"Research suggests benefit"	No study named	The study's name, who was compared with whom, and what was found, including trials that found nothing
"It regenerates cartilage" or "it reverses arthritis"	No study in the Cochrane review measured whether the joint changed on X-ray (Cochrane, above)	"We don't know that it changes the joint"
"Doctors who don't offer this are behind"	The American College of Rheumatology recommends against stem cell injections for knee and hip arthritis (ACR)	"The main rheumatology guideline recommends against this, and here is why we offer it anyway"
A "stem cell count" on a report	A same-day report can count cells with a nucleus; one review puts stem cells at "only 0.001% of nucleated cells" in marrow aspirate (SICOT-J)	A count with the method stated, and an explanation of what it can and cannot mean

Sources for the table: <a href="https://www.cochrane.org/evidence/CD013342what-are-benefits-and-risks-stem-cell-injections-knee-osteoarthritis”>Cochrane; ACR; <a href="https://www.sicot-j.org/articles/sicotj/fullhtml/2017/01/sicotj160095/sicotj160095.html”>SICOT-J, 2017.

Related pages: cell counts and the paperwork to ask for.

A transparent provider gives that version without being pushed, and says “we don’t know” when that is the answer.

Separating you from your doctor

“Your doctor doesn’t know about this” casts the person who knows your case as an obstacle. Advice to stop or change treatment for cancer, multiple sclerosis, rheumatoid arthritis or other immune conditions to fit an elective injection is the dangerous form of this pattern; that decision belongs to the doctor who prescribes the treatment.

A transparent provider coordinates with your other doctors about medicines and sends them its notes.

Escalation after failure

When a first injection does not help, the natural question is whether the diagnosis was right. Offering a more concentrated or more expensive product as the automatic next step skips that question. No trial cited on this site shows that people who did not respond to one injection do better with a pricier one.

A transparent provider re-checks the diagnosis first, and says when it would refer you elsewhere. It also explains how the needle will be guided without claiming that accuracy guarantees a result; accuracy is not a result, as ultrasound, fluoroscopy and what accuracy does and does not prove explains.

What regulators have done

• A court ruling on a fat-derived product. In 2019 the FDA announced the federal court decision described above, about a stem cell drug product made from a patient’s fat tissue (FDA, 2019, above).
• A settlement over unsupported claims. In 2018, the FTC reached a settlement that included a $3.31 million judgment and a ban on unsubstantiated health claims, and the FTC’s consumer protection director said clinics “must have solid evidence to back up their claims” (FTC, 2018, above).
• A lawsuit over joint pain marketing. In 2021, the FTC and Georgia’s attorney general sued the co-founders of a company that trained and supplied clinics, alleging “baseless pain-relief claims” for expensive injections, and called claims that the injections work as well as or better than surgery, steroid shots or painkillers “false or unsubstantiated” (FTC, 2021, above).

The FDA’s exception for reinjecting your own tissue during the same surgical procedure is narrow and separate from the rules for other cell products, which is why a clinic can be operating legally and still be selling something unproven. A lawyer, not this page, can say whether a particular clinic’s protocol fits.

What if something already went wrong?

Get medical care first if you have fever, spreading redness, or pain that is rapidly getting worse after an injection. Then the FDA asks patients to report problems with these products to its MedWatch Adverse Event Reporting program (FDA, above); the MedWatch page has the reporting form and lists 1-888-INFO-FDA (1-888-463-6332). To complain about a Tennessee-licensed practitioner, use the steps for how to file a complaint about a Tennessee practitioner. Keep your consent form, receipts and any report about what was injected. You have a right to copies of your records, and under HIPAA a provider “cannot deny you a copy of your records because you have not paid for the services you have received” (HHS).

Can a clinic avoid every pattern and still be the wrong choice?

Yes. A clinic can show one of these patterns out of careless marketing rather than bad intent, and a clinic that avoids all of them can still be selling a treatment with weak evidence. Recognizing the patterns protects you from the worst sales practices; it does not tell you whether the treatment will work for you. That question is separate, and the checks for it are in a step-by-step framework for judging a clinic and the consultation questions.

When should you walk away?

When you are asked to pay for an unapproved product outside a clinical trial, when the clinic claims an FDA approval it does not have, or when it will not give you a written price and a clear answer about what will be injected. Any one of those is enough on its own. The other patterns are reasons to slow down and get the missing answers in writing.

This page is general information, not medical advice.